磷酸化HSP27通过诱导NK细胞响应调控移植肝早期功能不全的机制研究
批准号:
82000617
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
鲁迪
依托单位:
学科分类:
消化系统器官移植
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
鲁迪
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
肝移植术后早期移植物功能不全(EAD)发生率高,进展迅速,缺乏早期预警和靶向干预手段,严重影响移植物和受者存活。我们前期分析肝移植蛋白磷酸化谱和动态免疫谱等发现,移植物再灌注后内源性损伤相关分子HSP27磷酸化水平、TLR4表达水平升高,而移植术/再灌注后早期外周血NK细胞向肝脏募集,促进急性肝损。我们进而提出假设:移植肝组织再灌注后HSP27发生磷酸化和胞外分泌,启动“损伤分子识别模式”活化TLR4通路,诱导NK细胞响应和下游炎症级联反应,最终导致肝移植术后EAD发生。本项目拟通过小鼠肝移植和再灌注损伤模型、临床肝移植样本动态监测等手段分析p-HSP27/TLR4通路与NK细胞间的交互关系,研究HSP27磷酸化诱导EAD发生的分子机制,以及其对术后EAD的早期预警效能。本研究旨在揭示移植肝再灌注后向EAD进展的关键分子生物学模式,鉴定肝移植术后EAD的干预靶点和早期预警分子标记物。
英文摘要
The incidence of early allograft dysfunction (EAD) after liver transplantation is very high. EAD develops quite fast, and there are no efficient therapeutic and prognostic strategies for EAD. Therefore, EAD adversely affects the graft and recipient survival. We previously performed dynamic protein phosphorylation profiling and immune spectrum profiling for liver transplantation, and found increased phosphorylation of HSP27 and TLR4 expression after reperfusion of the liver graft. Meanwhile, we observed the recruitment of NK cells into the liver graft after transplantation or reperfusion, which can cause further acute injury in the liver. Therefore, we assume that phosphorylation and secretion of HSP27 after reperfusion of the liver tissues will initiate the “Damage-related molecular pattern” and activate TLR4 signaling pathway, and then recruit and activate NK cells with subsequent inflammatory reaction in the liver graft, which finally causes EAD. Here we will focus on the regulation effect of p-HSP27 on TLR4 signaling and NK cell activation through mouse liver transplantation and reperfusion model and clinical transplant sample monitoring et al., so as to study the role of HSP27 phosphorylation in EAD and its predicting capacity for EAD in the early phase. The study aims to clarify the biological pattern of EAD, and identify the therapeutic target and early-phase biomarker for EAD after liver transplantation.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma.
一只芽,两只鸟:减轻缺血/再灌注损伤引起的炎症,以减少肝细胞癌的复发。
DOI:10.3389/fimmu.2022.879552
发表时间:2022
期刊:Frontiers in immunology
影响因子:7.3
作者:
通讯作者:
DOI:10.1111/cpr.13116
发表时间:2021-10
期刊:Cell proliferation
影响因子:8.5
作者:Yang X;Lu D;Wang R;Lian Z;Lin Z;Zhuo J;Chen H;Yang M;Tan W;Yang M;Wei X;Wei Q;Zheng S;Xu X
通讯作者:Xu X
DOI:10.1111/cpr.13568
发表时间:2023-10
期刊:Cell Proliferation
影响因子:8.5
作者:D. Lu;Xinyu Yang;Linhui Pan;Zhengxing Lian;W. Tan;Jianyong Zhuo;Modan Yang;Zuyuan Lin;Q. Wei;Jun Chen;Shusen Zheng;Xiao Xu
通讯作者:D. Lu;Xinyu Yang;Linhui Pan;Zhengxing Lian;W. Tan;Jianyong Zhuo;Modan Yang;Zuyuan Lin;Q. Wei;Jun Chen;Shusen Zheng;Xiao Xu
DOI:10.1007/s12015-022-10456-3
发表时间:2023-02
期刊:STEM CELL REVIEWS AND REPORTS
影响因子:4.8
作者:He, Chiyu;Lu, Di;Lin, Zuyuan;Chen, Hao;Li, Huigang;Yang, Xinyu;Yang, Modan;Wang, Kai;Wei, Xuyong;Zheng, Shusen;Xu, Xiao
通讯作者:Xu, Xiao
FGF21/ALOX15/15-HETE轴通过离子通道TRPV1调控移植肝早期免疫损伤的机制研究
- 批准号:82370662
- 项目类别:面上项目
- 资助金额:49万元
- 批准年份:2023
- 负责人:鲁迪
- 依托单位:
HIF-1α/CCL16调控肝细胞肝癌向胆管细胞表型转化的机制研究
- 批准号:LQ19H160030
- 项目类别:省市级项目
- 资助金额:0.0万元
- 批准年份:2018
- 负责人:鲁迪
- 依托单位:
国内基金
海外基金















{{item.name}}会员


